Connexion
M'inscrire

Votre recherche

Filtres

Project précédent
Projet suivant
Nous verifions auprès de chaque centre si des nouvelles informations sont disponibles

20999

Study aims to collect information in routine clinical practice in italy about the number of patients suffering from irregularly heart beats which are not caused by a heart valve problem (non-valvular atrial fibrillation, nvaf) who stopped or changed rivaroxaban treatment
Source : Importé depuis le centre

Référence clinicaltrials.gov: NCT04174859
Atrial Fibrillation (AF)
NVAF
Source :Importé depuis le centre
Recrutement fermé
Dernière modification : 2024/10/17
Type de recherche

Observationnel


Population cible

Condition médicale (spécialité visée)

Donnée non disponible

Profil des participants

Limites d'âge
minimum : 18 ans
Sexe(s) des participants

ALL

Source : Importé depuis le centre

Critères de sélection

Critères d'inclusion

Inclusion Criteria:

* Age \>= 18
* Patient with a diagnosis of NVAF
* New user to rivaroxaban, naïve or non naïve to treatment with oral anticoagulant
* Patient for whom the decision to initiate treatment with rivaroxaban was made as per physician's routine treatment practice for prevention of stroke and non-central nervous system (CNS) systemic embolism
* Signed an informed consent

Exclusion Criteria:

* Patient with heart valve replacement
* Patient is participating in an investigational program with interventions outside of routine clinical practice

Source : Importé depuis le centre

Thérapie ou Intervention proposée

Cohortes
Nom Condition médicale Traitement État du recrutement
NVAF patients Start treatment with rivaroxaban at the discretion of physician. Donnée non disponible
  • Inconnu
  • NVAF patients
    État du recrutement
    unknown
    Données à jour depuis : 17 octobre 2024

    Description de l'étude

    Résumé de l'étude

    While it is well known that stopping or changing medication with blood thinners in patients who suffer from non-valvular atrial fibrillation (NVAF) increases the risk of ischemic stroke (a condition which occurs when a vessel supplying blood to the brain is obstructed), bleeding or thromboembolism (a condition that happens when a blood clot forms elsewhere in the body and travels through the blood stream to plug another vessel), limited data are available on the number of NVAF patients and the reasons why NVAF patients in Italy stop or change their treatment with blood thinners to prevent stroke or thromboembolism.

    By following the NVAF patients in routine clinical practice in Italy who are treated with rivaroxaban to prevent stroke or systemic embolism researchers want to find out how many NVAF patients and for what reasons NVAF patients stopped or changed rivaroxaban treatment. Study data will be collected through patients' routine visits at their treating doctor over a period of 24 months for each patient.

    Source : Importé depuis le centre

    Sites

    Centres participants

      1 centres
    • MANY LOCATIONS

      Multiple locations

      WEST VIRGINIA, ARGENTINA

      Recrutement local
      État du recrutement: FERMÉ

    Dernière modification : 17 octobre 2024
    Données à jour depuis : 19 oct.
    Origine des données : clinicaltrials.gov
    Référence clinicaltrials.gov: NCT04174859